CIK 0000832489 · Non-accelerated filer<br>Smaller reporting company
GeoVax Labs, Inc.
Sign in to watch- Ticker
- GOVX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870455038
- Phone
- 678-384-7220
- Business address
- 1955 LAKE PARK DRIVE, SUITE 300, SMYRNA, GA
- Former names
- DAUPHIN TECHNOLOGY INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-09-21 | CHASE RANDAL D Director | Purchase | +10,000 | $1.10 | $11K | 36,613 |
| 2022-07-01 | Sharkey John W. VP, Business Development | Purchase | +1,000 | $0.82 | $820 | 2,860 |
| 2022-06-27 | McKee Kelly T. Jr. Chief Medical Officer | Purchase | +4,464 | $1.12 | $5K | 19,185 |
| 2022-06-21 | CHASE RANDAL D Director | Purchase | +10,000 | $1.21 | $12K | 26,613 |
| 2022-05-05 | McKee Kelly T. Jr. Chief Medical Officer | Purchase | +9,722 | $0.72 | $7K | 14,721 |
| 2022-05-04 | McKee Kelly T. Jr. Chief Medical Officer | Purchase | +4,999 | $0.71 | $4K | 4,999 |
| 2021-12-07 | SPENCER JOHN N JR Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2021-12-07 | MCNALLY ROBERT T Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2021-12-07 | Kollintzas Dean G Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2021-12-07 | CHASE RANDAL D Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2021-12-07 | NEWMAN MARK J Chief Scientific Officer | Grant or award · Common Stock (right to buy) | +25,700 | 25,700 | ||
| 2021-12-07 | Reynolds Mark CFO | Grant or award · Stock Option (right to buy) | +48,200 | 48,200 | ||
| 2021-12-07 | DODD DAVID A President, CEO | Grant or award · Stock Option (right to buy) | +103,000 | 103,000 | ||
| 2021-08-11 | DODD DAVID A President, CEO | Grant or award · Stock Option (right to buy) | +273,000 | 273,000 | ||
| 2021-08-11 | Reynolds Mark CFO | Grant or award · Stock Option (right to buy) | +128,000 | 128,000 | ||
| 2021-08-11 | NEWMAN MARK J Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2021-08-11 | Kollintzas Dean G Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2021-08-11 | MCNALLY ROBERT T Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2021-08-11 | CHASE RANDAL D Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2021-08-11 | SPENCER JOHN N JR Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 |
Page 4 of 6 · 107 trades